NDAINJECTIONINJECTABLE
Approved
May 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
OPTIRAY 350 (ioversol) by Guerbet is x-ray contrast activity [moa]. First approved in 1998.
Drug data last refreshed 10h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPTIRAY 350 (ioversol) is an injectable radiographic contrast agent used to enhance X-ray imaging and diagnostic procedures. It works through X-ray contrast activity, enabling improved visualization of blood vessels, organs, and tissue structures during radiological examinations. This non-ionic, osmotically balanced contrast medium is administered intravenously for cardiovascular and urographic imaging.
LOE Approaching
With LOE approaching and moderate competitive pressure (30%), this product faces declining market presence; commercial teams should expect resource reallocation toward pipeline products.
Mechanism of Action
X-Ray Contrast Activity
Pharmacologic Class:
Radiographic Contrast Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
OPTIRAY 350 offers limited career growth potential given its LOE-approaching status and mature market position. Professionals joining this product team should expect stable but declining roles, with emphasis on defending market share and managing generic competition rather than expansion.
Brand ManagerField Sales Representative
Worked on OPTIRAY 350 at Guerbet? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.